News on Hepatitis continually updated from thousands of sources around the net.
1 min ago | South China Morning Post
An announcement of a cure for a disease that affects millions across the globe is naturally greeted with relief and enthusiasm.
Trending on the Topix Network
4 hrs ago | Bellingham Herald
The Tulsa World reports that the bill would set forth the training required to obtain a permit as an oral surgery dental assistant.
8 hrs ago | Investor's Business Daily
Can biotech stocks bounce back? As recently as last month, the Medical-Biomed/Biotech group was ranked No.
12 hrs ago | Northern Michigan News
The record flooding in our area may carry a hidden danger - the threat of waterborne infections.
Port Alberni resident Maryann Rumney wants people to know that you don't have to wait until after you're dead to donate an organ to save someone.
ABSTRACT: Hepatitis C is a common cause of end-stage liver disease in the United States.
Hepatitis B, which is caused by the hepatitis B virus , is characterized by acute or chronic inflammation of the liver.
This week in the recall round-up gallery the reasons behind food withdrawals takes us to Norway, Belgium, Germany, the UK, USA, Canada and Australia.
Health authorities in England have approved an 18.7 million pound investment to provide Gilead Sciences' controversial new hepatitis C pill Sovaldi for seriously ill patients.
A friend who is an epidemiologist called the other day: "Hey Maria, did you know you're living in the middle of an epidemic?" he asked.
Sara C. Erickson, PharmD; Wenyi Qiu, MS; Crystal R. Maas-Patel, PharmD; Sharon M. Wang, PharmD, MS; and Bimal V. Patel, PharmD, MS Since the discovery of the hepatitis C virus in 1989, the chronically infected population has experienced dynamic change.
Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.
UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.
Deaths from viral Hepatitis B and C have surpassed HIV/AIDS in many countries, including Australia and in Western Europe, according to an analysis of the 2010 Global Burden of Disease study.
A combination of 2 direct-acting antivirals developed by Bristol-Myers Squibb , daclatasvir and asunaprevir, cured 90% of previously untreated people with genotype 1b hepatitis C in 24 weeks, without the need for pegylated interferon or ribavirin, Michael Manns of Hannover Medical School reported at the 49thEASL International Liver Congress in ... (more)
Editor at Biotech Week -- New research on Liver Diseases and Conditions is the subject of a report.